Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

MLA

den Bosch, Filip, et al. “Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.” Rheumatology and Therapy, vol. 4, no. 1, June 2017, p. 97. EBSCOhost, https://doi.org/10.1007/s40744-017-0065-3.

APA

den Bosch, F., Ostor, A., Wassenberg, S., Chen, N., Wang, C., Garg, V., & Kalabic, J. (2017). Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study. Rheumatology and Therapy, 4(1), 97. https://doi.org/10.1007/s40744-017-0065-3

Chicago

den Bosch, Filip, Andrew Ostor, Siegfried Wassenberg, Naijun Chen, Chen Wang, Vishvas Garg, and Jasmina Kalabic. 2017. “Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.” Rheumatology and Therapy 4 (1): 97. doi:10.1007/s40744-017-0065-3.